Genticel becomes “GenKyoTex”

February 28, 2017 Genticel’s General Meeting approves the strategic Combination with GenKyoTex SA Genticel (Euronext Paris & Brussels: FR00011790542 – GTCL), a biotechnology company developing innovative immunotherapies (the “Company”), and GenKyoTex SA, a...